Literature DB >> 12789276

Development of melanocyte precursors from the vertebrate neural crest.

Elisabeth Dupin1, Nicole M Le Douarin.   

Abstract

Pigment cells that differentiate in the vertebral skin arise from the neural crest (NC), a transitory structure formed at the dorsal borders of the neural plate and which gives rise to migratory cells of multiple fates. How NC cells become committed to the melanocytic lineage and what factors control the survival, proliferation and differentiation of melanocyte precursors remain largely unknown. These issues are of great importance for understanding the mechanisms of several pigment cell pathologies including melanomas. Recent in vivo and in vitro analyses of the fate of single NC cells have indicated that multipotent cells yield melanocyte precursors that become spatially and temporally segregated from other, non melanogenic, NC-derived cell types. The proper development of subsets of NC precursors is governed by environmental local cytokines acting in a paracrine manner. The conjunction of recent studies in mammals and birds reviewed here focuses on the action of endothelin 3 in controlling both the emergence and the maintenance of the NC-derived melanocyte phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789276     DOI: 10.1038/sj.onc.1206460

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

Review 1.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes.

Authors:  Igor Adameyko; Francois Lallemend
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

2.  FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism.

Authors:  Aaron J Thomas; Carol A Erickson
Journal:  Development       Date:  2009-04-29       Impact factor: 6.868

3.  Neural crest and Schwann cell progenitor-derived melanocytes are two spatially segregated populations similarly regulated by Foxd3.

Authors:  Erez Nitzan; Elise R Pfaltzgraff; Patricia A Labosky; Chaya Kalcheim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

4.  Identification of rat respiratory mucosa stem cells and comparison of the early neural differentiation potential with the bone marrow mesenchymal stem cells in vitro.

Authors:  Xin Gao; Jian Zhang; Jun Zhang; Hongjun Zou; Jinbo Liu
Journal:  Cell Mol Neurobiol       Date:  2013-11-30       Impact factor: 5.046

5.  Embryonic requirements for ErbB signaling in neural crest development and adult pigment pattern formation.

Authors:  Erine H Budi; Larissa B Patterson; David M Parichy
Journal:  Development       Date:  2008-05-28       Impact factor: 6.868

6.  Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

Authors:  Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

7.  Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs.

Authors:  Yvonne Mica; Gabsang Lee; Stuart M Chambers; Mark J Tomishima; Lorenz Studer
Journal:  Cell Rep       Date:  2013-04-11       Impact factor: 9.423

8.  Topology of feather melanocyte progenitor niche allows complex pigment patterns to emerge.

Authors:  S J Lin; J Foley; T X Jiang; C Y Yeh; P Wu; A Foley; C M Yen; Y C Huang; H C Cheng; C F Chen; B Reeder; S H Jee; R B Widelitz; C M Chuong
Journal:  Science       Date:  2013-04-25       Impact factor: 47.728

9.  P-cadherin counteracts myosin II-B function: implications in melanoma progression.

Authors:  Koen Jacobs; Mireille Van Gele; Ramses Forsyth; Lieve Brochez; Barbara Vanhoecke; Olivier De Wever; Marc Bracke
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

Review 10.  Primary mucosal melanomas: a comprehensive review.

Authors:  Marija Mihajlovic; Slobodan Vlajkovic; Predrag Jovanovic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.